Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of ABCB1 single-nucleotide polymorphisms on treatment outcomes with salmeterol/fluticasone combination therapy for stable chronic obstructive pulmonary disease.

Genetic testing and molecular biomarkers - 1 Oct 2015

Wang Xin-Wei, Zhang Yan-Lin, Xiong Ying

Abstract excerpt

OBJECTIVES: To investigate the relationship between ABCB1 single-nucleotide polymorphisms and the efficacy of salmeterol/fluticasone combination (SFC) inhalation therapy for stable chronic obstructive pulmonary disease (COPD) in a Chinese Han population. METHODS: A total of 362 patients with stable COPD were recruited between July 2012 and March 2014. Based on the therapeutic effects of lung function improvement...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Asian People

Share to ATP Binding Cassette Transporter, Subfamily B

Share to Genetic Association Studies

Share to Pulmonary Disease, Chronic Obstructive

Share to Treatment Outcome

Source

Identifiers

PMID: 26327575
DOI: 10.1089/gtmb.2015.0108

Genes

ABCB1
CAT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Impact of ABCB1 single-nucleotide polymorphisms on treatment outcomes with salmeterol/fluticasone combination therapy for stable chronic obstructive pulmonary disease.PMID 26327575Read ↗

Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on Stable Chronic Obstructive Pulmonary disease:study protocol of a randomized, double-blind, placebo-controlled trialSemantic proximity Read ↗

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.Semantic proximity Read ↗

Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Focus on Mutations - Part 1.Semantic proximity Read ↗

Advances in genome-wide association study of chronic obstructive pulmonary disease.Semantic proximity Read ↗

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.Semantic proximity Read ↗

Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.Semantic proximity Read ↗

Current Smoker: A Clinical Chronic Obstructive Pulmonary Disease Phenotype Affecting Disease Progression and Response to Therapy.Semantic proximity Read ↗

Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.